Novo Nordisk CEO Lars Fruergaard Jørgensen on This autumn outcomes, Wegovy demand and drug pipeline outlook

Share

CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen be part of ‘Squawk Field’ to debate the corporate’s quarterly earnings outcomes, demand for Wegovy, drug pipeline outlook, Cagrisema outcomes, weight problems drug pricing, state of Medicare drug value negotiations, and extra.

Supply hyperlink

Leave a Comment